Search Results

Filter
  • 1-10 of  7,885 results for ""PARTIAL thromboplastin time""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.

  • Authors : Berk ZBK; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Shah A

Subjects: Partial Thromboplastin Time* ; Whole Blood Coagulation Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

  • Source: Artificial organs [Artif Organs] 2022 Mar; Vol. 46 (3), pp. 501-505. Date of Electronic Publication: 2021 Nov 02.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients.

  • Authors : Kulig CE; University of California, Davis Medical Center, Sacramento, California.; Schomer KJ

Subjects: Extracorporeal Membrane Oxygenation* ; Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2021 Apr 01; Vol. 67 (4), pp. 411-415.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support.

  • Authors : Arnouk S; From the Department of Pharmacy, NYU Langone Health, New York, New York.; Altshuler D

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/*adverse effects

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2020 Mar; Vol. 66 (3), pp. 300-306.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/Extracorporeal Membrane Oxygenation/*adverse effects

  • Source: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2020 Mar; Vol. 66 (3), pp. 307-313.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9204109 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The accuracy of a point of care measurement of activated partial thromboplastin time in intensive care patients.

  • Authors : Karigowda L; Department of Intensive Care, St George Hospital, Kogarah, NSW, Australia. Electronic address: .; Deshpande K

Subjects: Partial Thromboplastin Time* ; Point-of-Care Systems*; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use

  • Source: Pathology [Pathology] 2019 Oct; Vol. 51 (6), pp. 628-633. Date of Electronic Publication: 2019 Aug 21.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Monitoring Unfractionated Heparin: A Review of Activated Partial Thromboplastin Time Versus Antifactor Xa.

  • Authors : Parker CR; Christine R. Parker is Clinical Pharmacy Specialist, Cardiothoracic Intensive Care Unit, Baylor University Medical Center, 3500 Gaston Ave, Dallas, TX 75246, (). Vivek Kataria is Clinical Pharmacy Specialist, Medical Intensive Care Unit, Baylor University Medical Center, Dallas, Texas.; Kataria V

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use ; Biological Monitoring/Biological Monitoring/Biological Monitoring/*standards

  • Source: AACN advanced critical care [AACN Adv Crit Care] 2019 Dec 15; Vol. 30 (4), pp. 305-312.Publisher: American Association of Critical-Care Nurses (AACN) Country of Publication: United States NLM ID: 101269322 Publication Model: Print Cited

Record details

×
Academic Journal

Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.

  • Authors : Oladunjoye OO; Department of Cardiovascular Surgery, Boston Children's Hospital, Boston, Mass.; Sleeper LA

Subjects: Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*adverse effects ; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects

  • Source: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2018 Jul; Vol. 156 (1), pp. 332-340.e1. Date of Electronic Publication: 2018 Apr 04.Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X

Record details

×
Academic Journal

Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors.

  • Authors : Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan .; Fujimori Y

Subjects: Clot Retraction* ; Partial Thromboplastin Time*; Anticoagulants/Anticoagulants/Anticoagulants/*pharmacology

  • Source: Journal of clinical pathology [J Clin Pathol] 2021 Apr; Vol. 74 (4), pp. 251-256. Date of Electronic Publication: 2020 Aug 12.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.

  • Authors : Ratano D; Service of Intensive Care and Burn Unit, Lausanne University Hospital (CHUV) and Faculty of Biology & Medicine, University of Lausanne, Lausanne, Switzerland. Electronic address: .; Alberio L

Subjects: Anticoagulants/Anticoagulants/Anticoagulants/*blood ; Factor Xa Inhibitors/Factor Xa Inhibitors/Factor Xa Inhibitors/*therapeutic use ; Heparin/Heparin/Heparin/*blood

  • Source: Thrombosis research [Thromb Res] 2019 Mar; Vol. 175, pp. 53-58. Date of Electronic Publication: 2019 Jan 07.Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation between activated partial thromboplastin time and anti-Xa activity in patients who received low-molecular weight heparin as anticoagulation for haemodialysis.

  • Authors : Wong SS; Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong.; Lau WY

Subjects: Partial Thromboplastin Time* ; Renal Dialysis*; Anticoagulants/Anticoagulants/Anticoagulants/*therapeutic use

  • Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2017 Nov; Vol. 22 (11), pp. 921-924.Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797

Record details

×
  • 1-10 of  7,885 results for ""PARTIAL thromboplastin time""